![]() |
市場調查報告書
商品編碼
1811735
全球醫用聚合物市場(按類型、製造技術、應用和地區分類)—預測至2030年Medical Polymer Market by Type (Medical Plastics, Medical Elastomers), Application (Medical Disposables, Medical Instruments and Devices, Prosthetics, Diagnostics Instruments and Tools), Manufacturing Technology, and Region - Global Forecast to 2030 |
預計醫用聚合物市場將從 2025 年的 447 億美元成長到 2030 年的 662.9 億美元,預測期內的複合年成長率為 8.2%。
隨著醫療保健、材料工程和以患者為中心的創新的不斷進步,醫用聚合物市場正在快速成長。關鍵促進因素包括對輕質、耐用且適用於生物相容性材料(例如植入、導管、診斷設備甚至手術器械)的需求。
調查範圍 | |
---|---|
調查年份 | 2022-2030 |
基準年 | 2024 |
預測期 | 2025-2030 |
對價單位 | 金額(百萬美元)、數量(千噸) |
部分 | 按類型、製造技術、應用和地區 |
目標區域 | 北美、歐洲、亞太地區、南美、中東和非洲 |
慢性病的增加、人口老化以及對微創手術的需求,促使人們對具有靈活性、安全性和精確性的先進聚合物偏好。盡可能向衛生和無污染的一次性醫療產品的重大轉變也促進了聚合物部件的廣泛採用。聚合物科學正在不斷發展,以創造出具有優異機械強度、耐用性、抗菌性能以及與主動滅菌技術相容性的聚合物和材料。知識和發展的進步帶來了形狀保持聚合物或生物可吸收聚合物的突破,為藥物傳輸裝置和組織工程創造了機會。醫療 3D 列印的廣泛使用透過快速開發客製化設計的植入和器械徹底改變了這一領域。此外,人們對永續性的日益關注導致人們對可回收和可生物分解聚合物的興趣日益濃厚。
醫用彈性體是醫用聚合物市場的第二大類別,這得益於其獨特的性能組合,包括柔韌性、耐用性和生物相容性,使其能夠用於數百種滿足關鍵醫療保健需求的精密應用。許多醫用彈性體應用涉及含有液體或需要持續運動、拉伸或壓縮的產品,例如密封件、墊圈、導管、注射器、柱塞和導管組件。醫用彈性體產品以其耐化學腐蝕、耐溫度變化和耐滅菌技術而聞名,能夠在高應力醫療應用中提供可靠的產品。文獻中經常引用矽橡膠、熱可塑性橡膠(TPE) 和橡膠材料,因為它們比傳統和剛性聚合物具有更高的舒適度,使其成為穿戴式醫療設備和皮膚接觸應用的首選。此外,最小化持續推動彈性體材料性能的提升,影響藥物傳輸系統、自動封裝和檢測系統以及生活方式診斷設備的先進設計方面也發揮著重要作用。此外,彈性體材料特別適合自動化生產和成型,其彈性模量和拉伸強度較低,從而能夠實現經濟高效的大量生產。再加上對現代醫療保健創新和安全的支持和推動,這些因素最終促使醫用彈性體成為醫用聚合物市場中一個快速成長且至關重要的類別。
拋棄式醫療用品是醫用聚合物市場的第二大應用,因為它們在維護醫療環境中的清潔度、病人安全和感染控制方面非常重要。注射器、手套、靜脈輸液袋、管路和連接器、外科用覆蓋巾和口罩都是一次性使用的,以防止交叉污染並維持無菌環境。由於對感染預防和支持感染控制的法規的重視,對一次性醫療用品的需求正在成長。聚丙烯、聚乙烯和聚氯乙烯是用於一次性醫療用品的主要聚合物,因為它們具有出色的加工性、低成本以及與滅菌製程的兼容性。住院時間的增加、外科手術的增加以及門診病人的增加正在推動對高品質拋棄式的需求,尤其是在新興地區。即用型無菌物品的便利性提高了繁忙的醫療環境中的效率。隨著醫療保健繼續強調安全性、成本效益和效率,預計聚合物一次性醫療用品仍將是關鍵的成長領域。
射出成型是醫用聚合物領域第二大製造技術,因為它能夠可靠且有效率地大規模生產高精度、複雜的零件。射出成型用於製造各種各樣的醫療產品,包括診斷設備外殼、手術器械手柄、注射器、連接器和植入式設備組件。射出成型與許多醫用級聚合物相容,包括聚碳酸酯、聚丙烯和ABS。它可以生產需要強度、生物相容性、耐化學性和清洗的零件。射出成型射出成型可以製造具有嚴格公差的複雜形狀,所有這些都與滿足醫療設備業的安全和性能要求有關。射出成型也易於自動化,從而可以經濟高效地批量生產高品質產品。多色注塑和微加工技術的最新進展進一步拓寬了其應用範圍。這些優勢凸顯了射出成型在醫用聚合物市場中的重要作用,支持產品創新並持續滿足對精密、可靠醫療產品的需求。
北美是醫用聚合物市場成長第二快的地區,主要得益於強勁的醫療保健動態和創新需求。美國不斷擴大的保險覆蓋範圍以及加拿大強勁的公共和私人醫療保健投資,正在推動人均醫療保健支出的成長。在醫療保健進步的推動下,預計北美在醫療設備、包裝和創傷護理類別中的成長將超過其他任何地區。然而,美國擁有世界上最具創新性的醫療保健環境之一,這得益於發達的醫療保健基礎設施、強大的研發 (R&D) 生態系統以及與聚合物產業的牢固夥伴關係。這導致了各種高性能聚合物的創造和擴展。其中許多聚合物為手術器械、診斷和藥物傳輸系統提供生物相容性甚至生物分解性(樹脂和纖維)。醫療保健產業依賴新產品設計和創新概念,以利用新產品開發(例如 PEEK 和其他工程塑膠)來成功推出符合患者偏好的產品,例如一次性用品、微創設備和居家照護。雖然亞太地區以最高的複合年成長率領先,但北美是成長第二快的地區。這得益於其強大的監管環境(以及美國的監管創新)、成熟的醫療保健體系,以及服務於患者和醫療保健產業的關鍵聚合物製造商,同時又不犧牲聚合物技術開發的創新。
本報告研究了全球醫用聚合物市場,按類型、製造技術、應用和地區進行細分,並提供了參與市場的公司概況。
The medical polymer market is projected to reach USD 66.29 billion by 2030 from USD 44.70 billion in 2025, at a CAGR of 8.2% during the forecast period. The medical polymer market is experiencing rapid growth as a result of continual progress in healthcare, materials engineering, and patient-focused innovation. Major factors driving include need for materials that are lightweight, durable, and suitable for use in situations involving biocompatible materials, like implants or catheters, diagnostic equipment, and even surgical instruments.
Scope of the Report | |
---|---|
Years Considered for the Study | 2022-2030 |
Base Year | 2024 |
Forecast Period | 2025-2030 |
Units Considered | Value (USD Million), Volume (Kiloton) |
Segments | Type, Application, Manufacturing Technology, and Region |
Regions covered | North America, Europe, Asia Pacific, South America, and Middle East & Africa |
The increased prevalence of chronic diseases, aging population, and the need for minimally invasive procedures is creating preference for advanced polymers that provide flexibility, security, and accuracy. The considerable shift in the use of disposable medical products, where possible, for sanitation and fewer contaminants has contributed to the proliferation of components made from polymers. The science of polymers is advancing to create polymers and materials with superior mechanical strength, durability, antimicrobial properties, and compatibility with active-sterilization techniques. Advances in knowledge and developments have resulted in breakthroughs in polymers that can hold shapes, or bioresorbable, that offer opportunities in the areas of drug delivery devices and tissue engineering. Proliferation of medical-grade 3D printing has revolutionized this area because custom-designed implants and devices can now be developed rapidly. There has increased attention on sustainable practices, leading to interest in recyclable and biodegradable polymers.
"Medical elastomers to account for the second-largest type in the medical polymer market during the forecast period."
Medical elastomers account for the second-largest type in the medical polymer market based on unique combinations of characteristics, such as flexibility, durability, and biocompatibility, allowing them to be used for hundreds of precise applications for critical healthcare. Many of the devoted elastomer applications are products used to contain fluids or products that need to be manipulated with constant movement, stretching, or compression, like seals, gaskets, tubing, syringes, plungers, and catheter components. Medical elastomer products are best known because of their chemical resistance, resistance to temperature swings, and resistance to sterilization techniques, which enables reliable products in high-stress medical applications. Because silicone elastomers, thermoplastic elastomers (TPE), and rubber materials are often specifically mentioned in literature due to increased comfort above conventional or hard polymers, they are favored for wearable medical devices and skin-contact applications. In addition, the influence of minimization continues to drive performance elastomeric materials, as do the advanced design aspects influencing drug delivery systems, automated enclosed testing systems, and lifestyle diagnostic devices. Furthermore, elastomeric materials are especially amenable to automated manufacturing and/or molding with E-modulus and tensile strength decreases, enabling cost-effective production in considerably large amounts. Combined with supporting and allowing innovation and safety in modern healthcare, these ultimately contribute to the fast-growing and extremely important category of medical elastomers in the medical polymer market.
"Medical disposables to account for the second-largest share of the medical polymer market during the forecast period."
Medical disposables are the second-largest application in the medical polymer market because of their importance in cleanliness, patient safety, and infection control in healthcare settings. Items such as syringes, gloves, IV bags, tubing and connections, surgical drapes, and masks are designed for single-use to prevent cross-contamination and maintain sterile environments. The emphasis on infection prevention and regulations supporting infection control have increased demand for disposable medical items. Due to their excellent processability, low cost, and compatibility with sterilizing processes, the polymers used in medical disposables are primarily polypropylene, polyethylene, and PVC. The increase in hospital stays, enhanced surgical procedures, and outpatient care, especially in emerging regions, are driving demand for good quality disposables. Convenience of ready-to-use pre-sterilized items can add efficiency in busy medical settings. As healthcare continues to focus on safety, cost-effective practices, and efficiencies, polymer medical disposables will be an important future growth area going forward.
"Injection molding is projected to be the second-largest manufacturing technology in the medical polymer market during the forecast period."
Injection molding is the second-largest manufacturing technology in the medical polymer space because it can produce highly precise and complex components at scale with good reliability and efficiency. Injection molding is used to produce a wide variety of medical products, for example, housing for diagnostic equipment, surgical instrument handles, syringes, connectors, components of implantable devices, and so forth. Injection molding is compatible with many medical-grade polymers, for example, it can be made from polycarbonate, polypropylene, and ABS. With injection molding, the manufacture of components that must have strength, biocompatibility, chemical resistance, and washability is possible. Injection molding can be made to tight tolerances with complex geometries; all of which are relevant in meeting the safety and performance requirements of the medical device industry. Injection molding is also compatible with automation and is conducive to produce items in large volumes while being cost-effective along with high quality output. Recent advancements in multi-shot and micro fabrication further enhances the application range as well. With all of these advantages it is easy to see how injection molding plays a critical role in the medical polymer market which supports product innovations and continues to aid the demand for sophisticated and reliable medical products.
"North America is projected to be the second-fastest growing region in the medical polymer market during the forecast period."
North America is the second-fastest growing region in the medical polymer market, due largely to strong healthcare dynamics, and innovated demand. Per capita healthcare expenses are rising, initiated by expanding insurance coverage in the US and strong public and private healthcare investments in Canada. The medical devices, packaging, and wound care categories are projected to account for greater growth in North America than any other region as healthcare advances. However, the US has one of the most innovative healthcare environments in the world based on a developed healthcare infrastructure, a strong Research and Development (R&D) ecosystem, and a strong partnership with the polymer industry, leading to the creation of a broad and expanding array of high-performance polymers. Many of these polymers have properties that are biocompatible and even biodegradable (resins and fibers) for surgical devices, diagnostics, and drug delivery systems. The healthcare industry relies on new product designs and innovative ideas regarding the use of new products developments (e.g., PEEK and other engineering plastics), to ensure successful product introduction that will also meet patients' preferences for disposable, minimally invasive, and home care solutions. While the Asia Pacific region is leading with the highest CAGR, North America is the second-fastest growing region, due to its regulatory strength (and US regulation innovation), established healthcare system, and leading region with polymer manufacturers serving patients and the medical sector without sacrificing innovation in the development of polymer technologies.
Extensive interviews with experts were conducted to determine and verify the market size for several segments and subsegments and the information gathered through secondary research.
BASF SE (Germany), SABIC (Saudi Arabia), Covestro AG (Germany), Celanese corporation (US), Evonik Industries (Germany), Arkema (France), Solvay (Belgium), Kuraray Co., Ltd. (Japan), Momentive Performance Materials Inc. (US), and DuPont (US), among others are some of the key players in the medical polymer market.
The study includes an in-depth competitive analysis of these key players in the medical polymer market, with their company profiles, recent developments, and key market strategies.
Research Coverage
The market study covers the medical polymer market across various segments. It aims to estimate the market size and the growth potential of this market across different segments based on type, application, manufacturing technology, and region. The study also includes an in-depth competitive analysis of key players in the market, their company profiles, key observations related to their products and business offerings, recent developments undertaken by them, and key growth strategies adopted by them to enhance their positions in the medical polymer market.
Key Benefits of Buying the Report
The report is expected to help the market leaders/new entrants in this market share the closest approximations of the revenue numbers of the overall medical polymer market and its segments and subsegments. This report is projected to help stakeholders understand the competitive landscape of the market, gain insights to improve the positions of their businesses, and plan suitable go-to-market strategies. The report also aims to help stakeholders understand the pulse of the market and provides them with information on the key market drivers, restraints, challenges, and opportunities.
Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the medical polymer market